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Abstract
Background: Matching and comparing sequence annotations of different reference
sequences is vital to genomics research, yet many annotation formats do not specify
the reference sequence types or versions used. This makes the integration of
annotations from different sources difficult and error prone.
Results: As part of our effort to create linked data for interoperable sequence
annotations, we present an RDF data model for sequence annotation using the
ontological framework established by the OBO Foundry ontologies and the Basic
Formal Ontology (BFO). We defined reference sequences as the common domain of
integration for sequence annotations, and identified three semantic relationships
between sequence annotations. In doing so, we created the Reference Sequence
Annotation to compensate for gaps in the SO and in its mapping to BFO, particularly
for annotations that refer to versions of consensus reference sequences. Moreover,
we present three integration models for sequence annotations using different
reference assemblies.
Conclusions: We demonstrated a working example of a sequence annotation
instance, and how this instance can be linked to other annotations on different
reference sequences. Sequence annotations in this format are semantically rich and
can be integrated easily with different assemblies. We also identify other challenges
of modeling reference sequences with the BFO.
Background
Sequence annotations and their relationship with reference sequences
Sequence annotations are information artifacts that add biologically meaningful informa-
tion to specific locations on genomic, gene, transcript or protein sequences. For example:
1) Gene OR4F5 is located on human chromosome 1 (build hg19), from position
69090 to 70008.
2) Substitution of C by T at location 178 of transcript reference sequence
NM_004006.2 results in nonsense variant Gln60* in protein reference sequence
NP_003997.1.
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Sequence annotations are only meaningful if the reference sequence is known. However,
specifying a stable reference is not necessarily straightforward. Before the Human Genome
Project, Locus Specific Databases (LSDB) were recommended for storing and sharing gene
centric variant annotations [1]. To date, the most popular platform for storing these tran-
script variants is the Leiden Open-source Variation Database v.2 (LOVD2) [2]. In each
LOVD2 instance, a “stable” transcript sequence is chosen as the reference sequence of
each gene. Variants are annotated with descriptions of sequence variations and positions
according to the chosen transcript sequence. There are many advantages of using gene/
transcript centric annotation approach. First, the length of a gene is much shorter than a
locus/chromosome, therefore maintaining the sequence content is much easier. Secondly,
it limits annotations mainly to the protein coding regions of the genome, therefore focus-
ing more on easy to predict phenotypic effects. However, LSDBs typically limit descrip-
tions of DNA variants to a single transcript, even when multiple transcripts may be
affected. Depending on which transcript is used, the variant description may look very
different. To calculate the location of a variant based on a different reference sequence, an
external conversion tool has to be used for the position conversion [3]. Disambiguation of
the variant description is an essential step in the context of data integration and
preservation.
However, not all biological questions are locus specific. As sequencing technologies
advanced in the past 15 years, more and more studies are omics focused, requiring a
“stable” and “complete” reference genome [4]. The Human Genome project was com-
pleted in April 2003, followed by the release of human genome assembly NCBI35/hg17 in
May 2004. Sequence gaps and assembly errors were removed and newly discovered genes,
(non-coding) transcripts and proteins were annotated with every new release up to
GRCh37/hg19 (February, 2009) [5]. As reference sequences are revised, it becomes
increasingly difficult to track and compare annotations. Researchers today share their
results of genome-wide genomic and epigenetic studies in publications and databases, but
they often fail to mention the exact version of the reference genome sequence. Moreover,
many popular annotation file formats do not explicitly ask for reference sequence version
information. It is up to the user to embed this information in the file description through
natural language. Consequently, when using these formats to exchange data for computa-
tional analysis and data integration, essential metadata is too easily lost. For example, the
ENCODE Project Consortium [6] has effectively shared their data by publishing them as
annotation tracks in the UCSC genome browser [7]. However, these annotation tracks use
Browser Extensible Data (BED) format, which does not explicitly state the reference
assembly version within the file. To propagate current annotations to the forthcoming
GRCh38/hg20 and alternative genome assemblies, it is crucial to preserve annotations
with their respective reference sequence versions.
A Semantic Web approach to data integration
A possible approach to exposing sequence variation annotations in a computer accessible
format is provided by Sematic Web languages and tools [8]. It effectively removes
the boundaries between annotating data, linking data, and making data machine readable
[9-11]. By representing data and metadata in Resource Description Framework (RDF) and
using shared ontologies in RDF and Web Ontology Language (OWL), mismatches
between database schema’s and the identity of its content can be addressed [12,13].
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A zfirst attempt for mutation data was presented by Zappa and coworkers, who produced
a mutation database for TP53 as Linked Open Data [14]. They followed the principles of
Linked Data [15] and applied various existing ontologies to achieve optimal interoperabil-
ity. However, they did not address the problem of integrating mutation data that were
annotated using different reference sequences. They did not model genomic locations of
annotations in detail, which makes querying this dataset difficult.
Ontological framework for data integration across resources
Formal ontologies play an important role in semantic data integration between informa-
tion systems [16,17], bringing conceptual coherence, stability, and scalability to the applied
domain, which can greatly increase data interoperability [17,18]. The Open Biological and
Biomedical Ontologies (OBO) Foundry provides a suite of orthogonal interoperable ontol-
ogies to aid knowledge integration in the biomedical domain [19]. To take advantage of
the OBO Foundry ontologies, we have chosen Basic Formal Ontology (BFO) [20] as our
upper ontological framework for data modeling [20]. Other ontologies in OBO that are
relevant to this paper include the Information Artifact Ontology (IAO) [21], the Sequence
Ontology (SO) [22], the Ontology for Genetic Interval (OGI) [23], and the Relation
Ontology (RO) [24].
Previous efforts on modeling biological sequences and sequence annotations in the OBO
community have taken primarily a biological viewpoint. Thus, sequences refer to biologi-
cal molecules, and sequence annotations refer to features defined with respect to biologi-
cal process [22,25]. The SO focuses on creating a set of consistent vocabularies that
describe the biological functions of these sequences and defining the biological relation-
ships between these sequences [22]. OGI models the biological physical sequence by
adopting the realism approach from BFO, and further contributes to this model by adding
spatial topological relationships between sequences [23]. However, Hoehndorf et al.
pointed out a gap between this biological model and information systems that are used to
store sequence annotations [26]. To bridge this gap, they have proposed three views of
biological sequences: molecular, syntactic, and abstract. Molecular sequences are DNA and
RNA molecules as well as proteins. Syntactic sequences are strings like “ACAC” and repre-
sent the arrangement of the molecules in the molecular sequences. Abstract sequences
represent an equivalence class of sequence tokens or representations. They point out that
without such a clear distinction data integration is hampered. Indeed, the SO community
acknowledged the lack of distinction that is made by biologists between abstract, syntactic,
and molecular sequences. Bada and Eilbeck proposed a strategy of separating SO into two
parallel ontologies: one for molecular sequences, the other with abstract sequences
(abstract in a broader sense than meant by Hoehndorf). The former would be an extension
of the Molecular Sequence Ontology while the SO would focus more on the abstract
sequences referring to sequences, and parts of sequences [27]. However, this new
alignment strategy is still under discussion.
Beyond the OBO Foundry there are additional relevant ontologies applicable to
sequence annotation. The Feature Annotation Location Description Ontology (FALDO)
is the latest effort to address the void of describing sequence annotations from the
information systems’ perspective [28]. It is designed to be general enough to describe
annotations with various level of location complexity, but not addresses issues such as
the meaning of or the evidence of the location.
Tatum et al. Journal of Biomedical Semantics 2014, 5(Suppl 1):S6
http://www.jbiomedsem.com/content/5/S1/S6
Page 3 of 13
Aim of this paper
Our aim is to create an RDF data model for describing sequence annotation instances
within an established ontological framework that fits our practice of working with refer-
ence sequences and different versions of genome assemblies. We provide a mechanism
for linking annotation instances to different reference sequences. We also present some
of the challenges in aligning our approach with current OBO Foundry ontologies.
Results and discussion
Describing sequence annotation instances
Our starting point for modeling sequence annotations was the BED format, a widely used
table-based format for sequence annotations that is easy to use and efficient to store (see
Figure 1). It typically consists of rows with a reference (e.g. a chromosome identifier), start
and end position on that reference, and a value for the annotation. Most UCSC genome
browser annotations can be downloaded as BED tracks. We started by deriving our RDF
model from the BED format: (i) we identified the desired upper ontological framework for
the domain of interest; (ii) we converted data in the BED track to RDF triples; (iii)
we further transformed the resulting triples by adding class definitions and ontology
mappings to the final model. We describe these steps below:
Upper ontological framework
We chose to use the BFO (version 1.1) as our top-level ontological framework. We
augmented BFO with a minimal Reference Sequence Annotation (RSA) ontology to
capture classes and predicates, and defined alignment strategies for RSA with OBO.
Data transformation to triples
As a preparative step, we first created annotation instances that closely matched our ori-
ginal data format. We created a ‘naive’ model for sequence annotation to directly trans-
late the information in the BED file with the addition of the reference assembly name
(Figure 2). Predicates linking the resource and its property values were derived from the
BED format description. At this stage, we used rdfs:Literal to capture concepts without
further ontological grounding (i.e., rdf:type relations). This data-centric approach to
semantic modeling is similar to the ‘syntactic’ conversion that is often used for integra-
tion of non-RDF resources, where table values are converted to literals, and table names
and headers to classes and properties without any further semantic modelling [29].
Figure 1 BED file examples. RefSeq transcript annotation in BED format on genome builds hg19 (a) and
hg18 (b). The second line contains the start and end positions of the NM_001005484 transcript encoded
by the OR4F5 gene that differ per assembly. Note that the BED file header line does not explicitly state the
reference sequence information. The submitter can only embed this information in the track description
through natural language.
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These naive models usually have limited semantic depth, such that finding common
elements for integration with other data sources can be difficult. Therefore, the model is
often linked to a more sophisticated, or personal model. In our case, we used the naive
model as a starting point in the modeling process, replacing it step by step by a more
precise model (Figure 3). Content of rdfs:Literals from the naive model were thus
converted to owl:instances, and class definitions were added. Below, we discuss our deri-
vation of the new model step-by-step, while explaining the placement of new RSA
classes and predicates, the reuse of existing ontologies, and potential problems with
OBO alignment. An RDF representation of the final model is shown as follows:
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .





:transcript a rsa:SequenceAnnotation ;
rsa:refseqID “NM_001005484";
rsa:isAnnotatedAt :location .




Figure 2 Naive model. Naïve transformation of a BED sequence annotation. Predicates used in this model
are placeholders and replaced in a later stage.
Figure 3 Semantic model. A sequence annotation instance after semantic transformation.
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rsa:hasOrientation rsa:forward
hg19:chr1 a rsa:ReferenceSequence ;
ro:integral_part_of hg19:assembly .
hg19:assembly a rsa:ReferenceAssembly .
Modeling locations on a reference sequence
We considered two approaches to harmonizing genomic location across different refer-
ence sequences. On the one hand, one may consider the location as an integral part of
the annotation. That is, if the location is changed, the annotation becomes a different
annotation. For example, variant annotations generally include the location of the
annotation as part of the identifier. Thus, the change of location results in change of
identifier of the annotation. On the other hand, a location can be considered an
instance separate from the annotation. In this way, a single annotation can be asso-
ciated with multiple locations and a single location can be associated with multiple
annotations. In our example, the second approach is more appropriate because it pro-
vides a mechanism to link an annotation to locations on different reference sequences
and sequence assemblies. Therefore, we created an instance of RSA:AnnotationLocation
:region, as the subject of positional properties. We defined the instance of hg19:assem-
bly and hg19:chr1 as ro:integral_part_of hg19:assembly. We linked :region to hg19:chr1,
which indirectly linked this annotation with the reference assembly.
In the example shown in Figure 3, we kept the :start and :end as rdfs:Literals. It is also
possible to convert the values of :start and :end to rdfs:Resource, and assign values to
these resources. However, we argue that :start and :end should be treated as data type
properties of a region. By doing so, we discourage linking of other RDF resources to :
region boundaries and the smallest linkable resource remained to be :region. Further-
more, in practice, using rdfs:Resource to describe the start and end of a region (simply
two numbers) leads to an explosion of triples. Hence, our model expresses instance data
in its simplest form. In contrast, FALDO defines :start and :end as instances of faldo:
Positions. It uses more triples (12 instead of 2) to describe the two points. A benefit of
FALDO’s approach is that it gives more flexibility to describe fussy regions.
Model strand-ness of sequence features
In contrast to RNA and protein, the stranded-ness of DNA sequences needs to be
addressed when modeling DNA sequence annotations. Because the two DNA strands
are the reverse complement of each other, information encoded in one orientation can
be derived from the other strand. Consequently, sequence records in DNA databases
contain only one of the two DNA strands (as the other stand can be inferred), but this
does not necessarily mean this is the strand an annotation pertains to. We have to
take this into account when modeling the strand in an annotation.
When annotations are only linked to the reverse strand of a reference sequence,
there are two conceptual annotation models. “Reverse strand annotations” can be
understood either as annotations on a sequence that is the reverse complement of a
reference sequence, or they can be understood as annotations on the reference
sequence, but their interpretations are based on the reverse complement. In the first
conceptualization, we need to link an annotation instance to a new sequence instance
that is the reverse complement of a known reference sequence. In the second concep-
tualization, the reverse-ness is a quality of the annotation similar to length being a
quality of a region. In practice, most sequence annotation systems specify coordinates
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using one strand as reference (the forward strand) and “strand” or “orientation” to
indicate which strand an annotation pertains to. Thus, the stranded-ness in our exam-
ple data refers to how annotations can be interpreted on single strand sequences. We
modeled this in our example RDF with :hasOrientation :forward.
We further argue that orientations of annotated regions are not limited to :forward
and :reverse. If an annotation represents a sequence feature of both strands, such as a
CpG Island, we consider the orientation of an annotation as :bidirectional. If the refer-
ence sequence is a syntactic sequence representing single strand molecules (RNA,
protein), or if the sequence feature does not rely specifically on the underlying
sequence (as in the case of a specific binding or chromatin features), the annotation
orientation is :none. As a result, the class for annotation orientation is defined as an
enumeration of four disjoint instances.
RSA:Orientation subclass of
{ RSA:forward, RSA:reverse, RSA:bidirectional, RSA:none } .
RSA classes and alignment with OBO
We have created instances using five classes from RSA. To enable better integration of our
data to existing linked data, we considered how to align RSA classes with OBO classes.
RSA:SequenceAnnotation can be regarded as an SO:sequence_feature with an anno-
tated location on a reference sequence. However, SO is currently not directly aligned
with BFO, although this is an ongoing effort [25]. To further improve the consistency
and interoperability of SO, new approaches to the BFO alignment were proposed.
Terms in SO could be distinguished as either molecular sequences (BFO:independent_-
continuant, IC) or abstract sequences (BFO:generically_dependent_continuant, GDC)
representing molecular sequences [27]. This distinction provides a foundation for the
alignment between SO and BFO. Following the same alignment strategy, we chose to
refer to SO:sequence_feature as a subclass of GDC. While it is not necessarily true that all
terms under SO:sequence_feature can be GDCs, it is outside the scope of this paper to
define which section of SO:sequence_feature falls into GDC. Because RSA:SequenceAnno-
tation is an information entity, we also considered to use IAO:information_content_entity
as its super class. However, it is not clear to us whether a class can be the subclass of both
SO:sequence_feature and IAO:information_content_entity, because the definition of SO:
sequence_feature under GDC is still under discussion. We therefore defer the alignment
between RSA:SequenceAnnotation and IAO:information_content_entity to the alignment
between SO and IAO. Meanwhile, IAO provides a useful link between database row
instances and annotation instances. For example, an instance of RSA:SequenceAnnotation
can be the object of IAO:is_about.
To summarize, we defined RSA:SequenceAnnotation as a subclass of BFO:generially_-




RSA:AnnotationLocation is a constraint on a reference sequence in terms of location
and orientation, with data properties such as a start point and an end point. We argue
that it should be classified as a GDC in BFO, because it cannot exist outside the context
of an annotation of a reference sequence. However, this prevents alignment with other
relevant classes in OBO. For instance, OGI:Biological_interval provides the location
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properties and it defines relationships between two instances of intervals such as by OGI:
isLocatedBefore. Nevertheless, OGI:Biological_Interval is defined as the “spatial continu-
ous physical entity” and a subclass of BFO:object, and thus a subclass of IC. In the con-
text of sequences, this defines an interval as a molecular sequence. Therefore, we only
defined relationships between the orientation, the reference, and the annotation location
in the scope of RSA.
RSA:AnnotationLocation subclass of
RSA:hasOrientation some RSA:Orientation and
RSA:mapsTo some RSA:ReferenceSequence
RSA:ReferenceSequence is about biological sequences, and modeling biological
sequences in ontologies is not easy [26]. In RSA, we defined RSA:ReferenceSequence as
a syntactic sequence. This is an information-bearing entity that contains a series of let-
ters from a given alphabet (i.e., ATGC for DNA). It can represent sequential informa-
tion captured by a biological molecule, but may represent a (possibly empty) set of
molecules. It can be stored in computer systems or on a piece of paper, therefore its
physical existence is an instance of IAO:information_content_entity. To correctly model
reference sequences, it is crucial to distinguish between the sequence content and the
file storing the sequence content, and therefore define RSA:ReferenceSequence not a
subclass of IAO:information_content_entity. For example, both transcript sequences
and chromosome sequences can be used as reference sequences, so instances of RSA:
ReferenceSequence can be ro:proper_part_of another instance. This part of relationship
is important for data integration scenarios shown in the next section, and this part of
relationship works only if RSA:SequenceAnnotation is defined by the sequence content,
as the sequence content of a transcript can be part of the sequence content of a chro-
mosome. However, if RSA:ReferenceSequence is defined as a subclass of IAO:informa-
tion_content_entity, the part of relationship cannot be modeled because the file of a
transcript sequence is not part of the file of the chromosome sequence.
In addition, we were confronted with the limitations of the reality constraint of BFO
[30]. In the field of sequence annotations, biologists often work with abstract entities that
only have an indirect relation to entities that exist in reality. For instance, the notion of a
consensus sequence is widely used in practice. Consensus sequences are hypothetical
sequences designed to capture information not from single molecules, but from sets simi-
lar molecules. In the case of reference sequence modeling we must accommodate consen-
sus sequences. If we modeled RSA:ReferenceSequence as a subclass of GDC, the instance
hg19:chr1 (chromosome 1 in human genome assembly version 19) inheres in an instance
of a corresponding molecular sequence. However, there is no molecular sequence that
corresponds with the sequence content of hg19:chr1, because hg19:chr1 is the consensus
of the sequence content of chromosome 1 of multiple people. The consensus sequence
modeling problem not only applies to sequences in genome assemblies, but also to all
sequences generated by Next Generation Sequencing technologies. Even in the context of
personal genome sequencing, a sequence may not be derived from a single molecule from
a single cell, but from a set of molecules from multiple cells. As discussed by Hoehndorf
et al., proper definitions of biological sequences require the upper ontological framework
to handle hypothetical sequences [26]. Thus, we argue that how to define a consensus
sequence within the framework of BFO and OBO needs to be addressed by the OBO
community. SO provides class SO:consensus_region for consensus sequences. However,
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this class is not aligned with BFO, and it is unclear whether this class is designed with
OBO principles.
Finally, RSA:ReferenceAssembly is an information entity encapsulating a set of RSA:
ReferenceSequences that are often used together to represent the total sequence content
of an organism, and RSA:ReferenceSequence is RO:proper_part_of RSA:ReferenceAssem-
bly. Its version number (in some cases, the timestamp) is crucial for data integration.
RSA:ReferenceAssembly cannot be aligned with BFO, because its parts are not aligned
with BFO.
Semantic relations between annotations
With a complete ontological framework in place, we then investigated how sequence
annotations using different reference sequences can be semantically linked. Semantic
relationships between sequence annotations are determined by the relationship
between their reference sequences. We categorized three types of reference sequence
relationships that are crucial for data integration: 1) The two reference sequences
represent the same biological entity; 2) One reference sequence is a syntactic part of
the other reference sequence; 3) One reference sequence can be syntactically derived
from the other reference sequence. Here, we show how each reference sequence rela-
tionship defines the relationship between annotations in Figure 4.
The same as relationship is important for integrating annotations based on different
reference assemblies (Figure 4A). For example, the gene annotation of OR4F5 based on
hg19 is the same as the one based on hg18. We note that the properties of the underlying
Figure 4 Semantic relationships between annotations. The sematic relationship between annotations is
determined by the relationship between their reference sequences. 1) An annotation is the same as
another annotation if their reference sequences represent the same biological entity. 2) An annotation is
equivalent of another if its reference sequence is syntactic part of the other reference sequence. 3) An
annotation is derived from another if it reference sequence is derived from the other reference sequence.
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reference sequence may differ, and hence the two annotations may have different proper-
ties (the start and end points on chromosome 1), but they share the same identifier
(OR4F5). The equivalent relationship is important for integrating annotations with differ-
ent sequence features (Figure 4B). For example, the variant annotation NM_004006.2:
c.178C>T is equivalent to variant annotation NC_000023.10:g.32867853G>A. Although
these two variant annotations are defined by different positions and different nucleotide
substitutions, they describe the same biological variation from two different viewpoints.
The c. notation uses transcript as the reference sequence and captures the effect of varia-
tion on RNA, whereas the g. notation uses chromosome as the reference sequence, and
captures the effect on the genome. The derived from relationship is important for connect-
ing annotations that occurred in different biological processes (Figure 4C). For example,
variant annotation on the protein level NP_003997.1:p.Gln60* is derived from variant
annotation on the transcript level NM_004006.2:c.178C>T.
Interoperability across reference assemblies
To define the relationship between reference sequences from different reference assem-
blies is not trivial. In line with semantic data integration strategies [29], our goal was to
define the common domain of integration across reference assemblies at the chromo-
some level. However, this domain of integration is outside the scope of RSA. Modeling
the relation between consensus sequence and chromosome in line with BFO was not
straightforward. In this section, we present three possible methods to connect reference
sequences across assemblies.
The first method uses the ‘inheres in’ property to relate the two instances of class
Chromosome 1 that then represent the common domain (Figure 5A). This approach
seems to follow BFO. However, we did not find an existing superclass for Chromosome
1, because hg19:chr1 and hg18:chr1 are consensus sequences that do not inhere in any
particular chromosome. The superclass for Chromosome 1 would require an equivalent
of a consensus chromosome that is a subclass of IC, which we have shown in the last
section is not currently possible.
The second method is perhaps the least attractive, because it defines a relationship
between an OWL:Individual and an OWL:Class that is not a class assertion, violating
the OWL-DL definition and making reasoning over datasets undecidable. However,
this method eliminates the need for ‘real chromosome instances’ required by the
‘inheres in’ relationship in the first method (Figure 5B).
The third method uses a single instance of an abstract class Chromosome 1 (Figure 5C),
using the Genome Component Ontology (GCO). GCO does not follow BFO’s realism view-
point, and is intentionally kept as minimal as possible. It defines the abstract division of
the total genetic information of an organism by its physical separation into different com-
ponents, but not to describe any specific characteristics derived through experimentation.
Instances of GCO:GenomeComponent provide high level references. More specific descrip-
tions, such as gene content, length, function, location, loci or sequence, can be linked to
instances representing instances of GCO:GenomeComponent.
Each method has advantages and disadvantages. We consider method 3 the best
option for data integration, because it offers good features for linking and integrating
data without violating OWL-DL restrictions. A disadvantage is that it is not aligned
with BFO, which may impede integration with data annotated using a BFO-based
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ontology. Therefore, we retained only the minimal set of classes in GCO. The RDF repre-
sentation for the model shown in Figure 4C is accessible at http://rdf.biosemantics.org/
examples/gco_integration.
Conclusions
We demonstrated a working data model of sequence annotations that can be preserved
across different reference sequence assemblies. This data model uses the ontology of Refer-
ence Sequence Annotation, which is available at http://purl.bioontology.org/ontology/RSA.
We also demonstrated that within the scope of our model, BFO could not accommodate
all instances required for our purpose when we followed the realism constraint defined by
BFO and restrict instances to OWL-DL. However, we cannot exclude that different view-
points towards modeling genome annotations can provide new insights that would fit the
current BFO. GCO was created as our best effort to provide interoperability across
reference assemblies, which is available at http://purl.bioontology.org/ontology/GCO.
The alignment between RSA, GCO, and OBO will be an ongoing effort.
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